Martin Cholette has a passion for the intersection of engineering and medicine. He has degrees in Computer Science and Biomedical Sciences from the University of Montreal, which laid the foundation for his 29 year career in medical device development with a focus on class III active implantable medical devices. His experience encompasses a variety of technologies, including pacemakers, defibrillators, cardiac resynchronization devices, spinal cord stimulation devices, deep brain stimulation devices, and artificial pancreas technology. Martin held several key roles throughout his career, most notably as a Distinguished Engineer at Medtronic Diabetes. His experience also includes positions in firmware development, medical technology, program management, systems engineering, and clinical engineering at St. Jude Medical. He held the role of Vice President of Research and Development for Integer Holdings Corporation, where Martin led a team of nearly 200 engineers, driving innovation and development in the field of medical devices.
From 2001 to 2012, Martin was an instructor in the Master’s of Biomedical Engineering program at Cal Poly University. During his tenure, he taught courses in neuroengineering, human physiology, cardiac physiology, and medical device development. Martin co-authored several articles published in peer-reviewed journals. He holds 22 issued U.S. patents and over 40 published patent applications. Martin is a previous member of the ISO Standards Committee for MRI Compatibility of Active Implantable Medical Devices, contributing to the development of standards for the industry. Additionally, he holds a certification from the International Board of Heart Rhythm Examiners for Special Competency in Pacing and Defibrillation.